Breast Surgery Practice Questions

Q: In patients with breast cancer, chest wall involvement means involvement of any one of the following structures except?

Pectoralis. In the TNM staging of breast cancer (AJCC 8th Edition), the definition of **T4b (Chest Wall Involvement)** is a critical high-yield concept for NEET-PG. ### **Explanation of the Correct Answer** The correct answer is **Pectoralis (Option B)**. In clinical staging, "chest wall involvement" specifically refers to the invasion of structures deep to the breast's posterior capsule. While the breast lies directly over the Pectoralis major muscle, invasion of the **Pectoralis major or minor muscles** does **not** constitute T4 disease or chest wall involvement. It is still staged based on the size of the tumor (T1, T2, or T3). ### **Analysis of Incorrect Options** According to the AJCC guidelines, chest wall involvement (T4a) is defined by the invasion of: * **Ribs (Option D):** Direct osseous invasion. * **Intercostal Muscles (Option C):** Invasion into the muscles between the ribs. * **Serratus Anterior (Option A):** Invasion into this muscle, which forms part of the medial wall of the axilla and deep boundary of the lateral breast. ### **Clinical Pearls for NEET-PG** * **T4a Definition:** Extension to the chest wall (ribs, intercostals, or serratus anterior). * **T4b Definition:** Edema (including peau d'orange), ulceration of the skin, or satellite skin nodules. * **T4c:** Both 4a and 4b. * **T4d:** Inflammatory carcinoma (a clinical diagnosis). * **Fixed to Pectoralis:** If a tumor is fixed to the pectoralis muscle but not the chest wall, it is **not** T4. This is a common "trap" question in surgical oncology. * **Management:** T4 tumors are generally considered Locally Advanced Breast Cancer (LABC) and typically require Neoadjuvant Chemotherapy (NACT) before surgical intervention.

Q: Prognosis of breast cancer is best determined by:

Axillary node involvement. ### Explanation **1. Why Axillary Node Involvement is Correct:** In breast cancer, the **axillary lymph node status** is the **single most important prognostic factor** for recurrence and overall survival. The lymphatic system is the primary route for systemic dissemination. The number of involved nodes directly correlates with the risk of distant metastasis; for instance, patients with zero involved nodes have a significantly higher 10-year survival rate compared to those with four or more involved nodes. **2. Analysis of Incorrect Options:** * **B. Skin infiltration:** While skin involvement (T4 status) indicates advanced stage (Stage IIIB) and a poorer prognosis, it is not as statistically significant a predictor of long-term survival as nodal status. * **C. Size of the tumour:** Tumor size (T) is the second most important prognostic factor. While larger tumors generally have a higher risk of metastasis, a small tumor with positive nodes has a worse prognosis than a larger tumor with negative nodes. * **D. Estrogen receptor (ER) status:** This is a **predictive factor** rather than the primary prognostic factor. It helps determine the response to hormonal therapy (like Tamoxifen). While ER-positive status generally suggests a better short-term outcome, it does not override the prognostic weight of nodal involvement. **Clinical Pearls for NEET-PG:** * **Most important prognostic factor:** Axillary lymph node status. * **Second most important prognostic factor:** Tumor size. * **Sentinel Lymph Node Biopsy (SLNB):** The gold standard for axillary staging in clinically N0 (node-negative) patients. * **Nottingham Prognostic Index (NPI):** Uses tumor size, lymph node stage, and histological grade to calculate prognosis. * **Triple Negative Breast Cancer (TNBC):** Carries the worst prognosis among molecular subtypes due to the lack of targeted therapy options.

Q: Which of the following is a complication of post-mastectomy lymph accumulation?

Lymphosarcoma. **Explanation:** The correct answer is **Lymphosarcoma**, specifically referring to **Stewart-Treves Syndrome**. **1. Why Lymphosarcoma is correct:** Chronic lymphedema (lymph accumulation) following a radical mastectomy with axillary lymph node dissection leads to localized immune deficiency and chronic lymphatic stasis. Over a long period (typically 10–20 years), this can trigger the development of a rare, highly aggressive vascular tumor known as **Angiosarcoma** (historically and in some exam contexts referred to as lymphosarcoma). This specific clinical entity—angiosarcoma arising in a chronically lymphedematous limb—is known as **Stewart-Treves Syndrome**. **2. Why other options are incorrect:** * **A & B (Metastases/Recurrence):** While cancer can recur or spread after surgery, these are consequences of the primary malignancy's biology or inadequate clearance, not a direct complication of the *accumulation of lymph* itself. * **D (Pain):** While lymphedema causes discomfort and a sense of heaviness, "pain" is a non-specific symptom and not a pathological "complication" in the same category as a secondary malignancy like Stewart-Treves Syndrome. **3. NEET-PG High-Yield Pearls:** * **Stewart-Treves Syndrome:** Classically presents as purple/blue skin nodules or plaques on the arm 10+ years after mastectomy. * **Risk Factor:** Most commonly associated with the **Halsted Radical Mastectomy** due to the extensive nature of the lymphadenectomy. * **Diagnosis:** Requires a skin biopsy; the prognosis is generally poor due to early metastasis. * **Differential:** Do not confuse this with "Lymphangiosarcoma," though the terms are often used interchangeably in older textbooks. The modern pathological term is **Cutaneous Angiosarcoma**.

Q: What does a BIRADS score of 4 suggest?

Suspicious of malignancy. **Explanation:** The **BI-RADS (Breast Imaging-Reporting and Data System)** is a standardized scoring system used by radiologists to communicate the risk of malignancy in breast lesions. **Why Option B is Correct:** A **BI-RADS 4** score is defined as **"Suspicious Abnormality."** These lesions do not have the classic appearance of cancer but possess features that make malignancy a possibility. Because the risk of malignancy ranges from **2% to 95%**, a tissue diagnosis (biopsy) is mandatory for all BI-RADS 4 lesions. **Analysis of Incorrect Options:** * **Option A (Normal):** This corresponds to **BI-RADS 1**, where there are no findings to report and the risk of malignancy is 0%. * **Option C (Mostly Benign):** This corresponds to **BI-RADS 3** (Probably Benign). These lesions have a 95% risk). **High-Yield Clinical Pearls for NEET-PG:** * **BI-RADS 0:** Incomplete assessment; needs further imaging (e.g., comparison with old films or ultrasound). * **BI-RADS 2:** Benign findings (e.g., simple cysts, stable fibroadenomas); 0% risk of malignancy. * **Sub-classification of BI-RADS 4:** * **4A:** Low suspicion (2–10% risk) * **4B:** Moderate suspicion (10–50% risk) * **4C:** High suspicion (50–95% risk) * **Management Rule:** BI-RADS 4 and 5 always require pathological correlation (Core Needle Biopsy is the gold standard).

Q: What is the best time for breast self-examination (BSE)?

One week after menstruation. **Explanation:** The correct answer is **Option D: One week after menstruation.** **Why it is correct:** The primary goal of Breast Self-Examination (BSE) is to detect abnormal lumps or changes. During the menstrual cycle, breast tissue is highly sensitive to hormonal fluctuations (estrogen and progesterone). In the pre-ovulatory and pre-menstrual phases, hormonal stimulation causes increased vascularity, water retention, and glandular engorgement, making the breasts feel tender, firm, or "lumpy" (physiologic nodularity). The **best time** for BSE is **7 to 10 days after the first day of the menstrual period** (the early follicular phase). At this point, estrogen and progesterone levels are at their lowest, breast engorgement has subsided, and the tissue is softest and least tender, making it easier to palpate true underlying masses. **Why other options are incorrect:** * **Option A (One week before menstruation):** This is the luteal phase where progesterone is high. Breasts are often swollen and tender, which can lead to false-positive findings or discomfort during examination. * **Options B & C (Ovulation/Post-ovulation):** During and immediately after ovulation, rising estrogen levels begin the process of fluid retention and ductal proliferation, which can obscure small lesions. **NEET-PG High-Yield Pearls:** * **Post-menopausal/Pregnant women:** Since they do not have cycles, they should perform BSE on a **fixed date every month** (e.g., the 1st of every month) to maintain consistency. * **BSE Utility:** While BSE is a common recommendation for "breast awareness," large trials have shown it does not reduce mortality. However, it remains a high-yield exam topic for screening protocols. * **Clinical Triad:** The gold standard for breast cancer diagnosis is **Triple Assessment**: Clinical examination, Imaging (Mammography/USG), and Pathology (FNAC/Biopsy).

Q: A 14-year-old healthy girl, with normal height and weight for her age, complains that her right breast has developed twice the size of her left breast since the onset of puberty at age 12. Both breasts have similar consistency on palpation with normal nipples and areolae. What is the most likely cause for these findings?

Virginal hypertrophy. **Explanation:** The correct answer is **Virginal Hypertrophy** (also known as Juvenile Hypertrophy). **1. Why Virginal Hypertrophy is correct:** Virginal hypertrophy is characterized by rapid, often massive, enlargement of one or both breasts during or shortly after puberty. It is thought to be caused by an abnormal end-organ sensitivity to normal levels of estrogen. In this case, the patient is 14 years old (post-pubertal), and the breast tissue is described as having a **normal consistency** without discrete masses, which is the hallmark of this condition. While it can be bilateral, it is frequently asymmetrical, as seen in this patient. **2. Why the other options are incorrect:** * **Cystosarcoma Phyllodes:** While it can cause rapid breast enlargement, it typically presents as a **firm, mobile, well-defined, multinodular mass** (leaf-like architecture). It is rare in 14-year-olds and would not present with "normal consistency" on palpation. * **Fibrocystic Disease:** This usually presents in women aged 30–50. It is characterized by cyclical mastalgia (pain) and "lumpy" breast texture (nodularity), not massive unilateral enlargement in a teenager. * **Early stage of carcinoma:** Breast cancer is extremely rare in the pediatric/adolescent population. Early-stage carcinoma typically presents as a painless, hard, solitary lump rather than diffuse enlargement of the entire breast. **Clinical Pearls for NEET-PG:** * **Management:** The initial treatment for Virginal Hypertrophy is often observation or hormonal therapy (e.g., Tamoxifen), but definitive treatment for stable, severe cases is **reduction mammoplasty** (once breast growth has ceased). * **Differential Diagnosis:** Always differentiate from a **Giant Fibroadenoma**, which presents as a discrete, encapsulated mass, whereas Virginal Hypertrophy involves diffuse enlargement of the entire breast stroma. * **Key Age Group:** Typically occurs between ages 11 and 14.

Q: A 50-year-old woman complains of intermittent bleeding from the left nipple over the past 3 months. No mass is palpable, but a bead of blood can be expressed from the nipple. What is the ideal procedure in this case?

Microdochotomy. ### Explanation The clinical presentation of **spontaneous, unilateral, single-duct bloody nipple discharge** in the absence of a palpable mass is the classic triad for an **Intraductal Papilloma**. This is the most common cause of bloody nipple discharge. **Why Microdochotomy is the Correct Choice:** Microdochotomy (also known as microdochectomy) is the surgical excision of a **single offending duct**. In this patient, the ability to express blood from a specific point on the nipple allows for the identification of the involved duct. The procedure is both diagnostic (to rule out papillary carcinoma) and therapeutic (to stop the bleeding). It is the gold standard when the discharge is localized to a single duct. **Analysis of Incorrect Options:** * **Option A:** Cytological examination of nipple discharge has a high false-negative rate and low sensitivity for detecting malignancy. Observation is inappropriate as a pathological cause must be ruled out. * **Option B:** Segmental excision (or Wide Local Excision) is too extensive for a non-palpable lesion and is typically reserved for confirmed malignancies or larger benign masses. * **Option D:** Simple mastectomy is an aggressive over-treatment for a condition that is most likely a benign intraductal papilloma. **NEET-PG High-Yield Pearls:** * **Most common cause of bloody nipple discharge:** Intraductal Papilloma. * **Most common cause of nipple discharge overall:** Duct Ectasia (usually multicolored/greenish). * **Investigation of choice:** Triple assessment (Clinical, Imaging like Galactography/Ultrasound, and Histology). * **Hadfield’s Procedure (Total Duct Excision):** Preferred over microdochotomy if the discharge comes from **multiple ducts** or if the patient is older and not planning to breastfeed.

Q: Carcinoma breast spread to the other breast is more common in which type of breast carcinoma?

Lobular carcinoma. **Explanation:** **Invasive Lobular Carcinoma (ILC)** is characterized by a unique growth pattern and a high propensity for **multicentricity** (multiple foci in the same breast) and **bilaterality** (involvement of the contralateral breast). 1. **Why Lobular Carcinoma is correct:** The hallmark of ILC is the loss of the cell-adhesion molecule **E-cadherin**. This leads to the characteristic "Indian file" pattern where cells lack cohesion and infiltrate the stroma individually. Because these cells do not form a solid mass early on, the disease is often clinically occult and diffuse. Statistically, ILC has a significantly higher rate of bilateral involvement (up to 10–15%) compared to other types, making it the most common subtype to spread to or arise in the opposite breast. 2. **Why other options are incorrect:** * **Scirrhous Carcinoma:** This is a descriptive term for a subtype of Invasive Carcinoma of No Special Type (NST/Ductal) characterized by dense fibrous stroma (desmoplasia). While it is the most common clinical presentation of breast cancer, it is typically a localized, unifocal mass and does not share the same high risk of bilaterality as ILC. * **Options C & D:** These are incorrect as the biological behavior regarding bilaterality is specific to the lobular subtype. **High-Yield Clinical Pearls for NEET-PG:** * **Most common site of metastasis for ILC:** Unlike ductal carcinoma, ILC frequently spreads to unusual sites like the **peritoneum, GI tract, ovaries, and leptomeninges**. * **Imaging:** ILC is notorious for being "mammographically silent" due to its diffuse growth; **MRI** is the most sensitive modality for determining its true extent. * **E-cadherin:** Negative staining for E-cadherin is the definitive immunohistochemical marker to differentiate Lobular from Ductal carcinoma.

Question 1

In patients with breast cancer, chest wall involvement means involvement of any one of the following structures except?

Accepted Answer

Pectoralis

Answer

Serratus anterior

Answer

Intercostal muscles

Answer

Rib

Question 2

Prognosis of breast cancer is best determined by:

Accepted Answer

Axillary node involvement

Answer

Skin infiltration

Answer

Size of the tumour

Answer

Estrogen receptor status

Question 3

Which of the following is a complication of post-mastectomy lymph accumulation?

Accepted Answer

Lymphosarcoma

Answer

Metastases of cancer

Answer

Recurrence of cancer

Answer

Pain

Question 4

Paget's disease of the breast is a manifestation of which of the following?

Accepted Answer

Ductal carcinoma

Answer

Lobular carcinoma

Answer

Ductal carcinoma in situ (DCIS)

Answer

Lobular carcinoma in situ (LCIS)

Question 5

What does a BIRADS score of 4 suggest?

Accepted Answer

Suspicious of malignancy

Answer

Normal lesion

Answer

Mostly benign

Answer

Proven malignancy

Question 6

What is the best time for breast self-examination (BSE)?

Accepted Answer

One week after menstruation

Answer

One week before menstruation

Answer

During ovulation

Answer

Two to three days post-ovulation

Question 7

A 14-year-old healthy girl, with normal height and weight for her age, complains that her right breast has developed twice the size of her left breast since the onset of puberty at age 12. Both breasts have similar consistency on palpation with normal nipples and areolae. What is the most likely cause for these findings?

Accepted Answer

Virginal hypertrophy

Answer

Cystosarcoma phyllodes

Answer

Fibrocystic disease

Answer

Early stage of carcinoma

Question 8

A 50-year-old woman complains of intermittent bleeding from the left nipple over the past 3 months. No mass is palpable, but a bead of blood can be expressed from the nipple. What is the ideal procedure in this case?

Accepted Answer

Microdochotomy

Answer

Cytological examination of discharge and, if no malignant cells, careful observation

Answer

Segmental excision of the breast

Answer

Simple mastectomy

Question 9

Carcinoma breast spread to the other breast is more common in which type of breast carcinoma?

Accepted Answer

Lobular carcinoma

Answer

Scirrhous Carcinoma

Answer

Both of the above

Answer

None of the above

Question 10

In the Patey procedure, what is done regarding the pectoralis muscles?

Accepted Answer

Removal of pectoralis minor and preservation of pectoralis major

Answer

Removal of both pectoralis major and minor

Answer

Pectoralis minor is divided

Answer

Both pectoralis major and minor are preserved

Breast Surgery — MCQs

Breast Surgery — MCQs

On this page

Practice by Chapter

Want unlimited practice?